NEWS

https://www.utu.fi/en/news/press-release/new-and-crucial-role-discovered-for-a-protein-in-the-bodys-immunity-against#:~:text=Researchers%20at%20the%20University%20of,immune%20system’s%20defence%20against%20cancer.

30th September 2022

Congratulations, Mona!!πŸ‘πŸ»πŸŽ‰πŸΎ

Our Ph.D. student, Mona, has just been awarded two grant: this time the competitive Travel Awards from the Turku Doctoral Programme of Molecular Medicine!πŸ˜ƒπŸ’ͺβœ¨πŸ‘πŸ»

24th August 2022
Congratulations, Saara! πŸŽ‰

Today, our Ph.D. student, Saara Koskela, was awarded the 1st Prize in the Project Presentation competition during the 31st BioCity Symposium!!🀩πŸ₯‡πŸ†

Congratulations Saara, this is the result when you give your best!πŸ‘πŸ‘βœ¨πŸŽ‰

2nd June 2022

Congratulations, Mona! πŸŽ‰

Our Ph.D. student, Mona Wang, has just been awarded a competitive grant of $30,000.00!!πŸ™πŸ†πŸ˜±

You deserve it for your hard work and for being active in publishing your research. Every strong castle is built of several stone blocks! Well doneπŸ’ͺ🏻!

1st July 2022

MIORG attracts renowned international collaborators to Finland!

Professor Sarah E. Coupland from Liverpool is our Visiting Professor in the InFLAMES flagship. It has been delightful to watch her amazing lectures, in addition to a profound meditation on how to strive for a successful academic career with all the challenges that come along on all fronts, and still maintaining a noble meaningful life full of personal achievements. From a modest early career stage until coming to prominence as the president of different funding institutions and scientific societies, Sarah shared the most important tips and tricks we need to bear in mind for academic success, with the most important aspect being persistence. 

Sarah had a very busy schedule in 2021 where she also managed to provide with excellent scientific lectures regarding rare tumors that hide the knowledge gaps of cancer immune escape. From her lectures, we could better grasp how difficult is to factor the most refractory cancer type to current immunotherapies, uveal melanoma. Despite the difficulties for developing proper in vivo models that would accelerate preclinical research in uveal melanoma, Sarah’s group advanced in establishing important scientific grounds, mostly given to the foundation of what is considered today one of the largest and successful biobanks for these rare intraocular tumors. 

It has been a good year in 2022 for our group as one of the contributors of the InFLAMES flagship. Prof. Coupland is our active collaborator in the Jane and Aatos Erkko Foundation project, the Juselius funding programme, and our Academy of Finland project in developing new adjuvant treatments to improve current immunotherapies for both cutaneous and ocular melanomas.

1st January 2022

Congratulations, Eleftheria!!πŸŽ‰

Eleftheria Maranou has been awarded a 2-year Fellowship from the Turku Doctoral Programme of Molecular Medicine (TuDMM)! Great Job 🀩✨

You did it! Great project writing and presentation!!πŸ’ͺ🏻

22nd December 2021

Thank you, team! 🀩

Such lovely Christmas memory!πŸŽ